Compare MTLS & AIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MTLS | AIRS |
|---|---|---|
| Founded | 1990 | 2012 |
| Country | Belgium | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Nursing Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 387.8M | 328.7M |
| IPO Year | 2014 | 2021 |
| Metric | MTLS | AIRS |
|---|---|---|
| Price | $7.07 | $2.43 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 96.6K | ★ 1.0M |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $151,818,000.00 |
| Revenue This Year | $6.38 | $5.19 |
| Revenue Next Year | $6.45 | $5.32 |
| P/E Ratio | $61.39 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.78 | $1.51 |
| 52 Week High | $7.50 | $12.00 |
| Indicator | MTLS | AIRS |
|---|---|---|
| Relative Strength Index (RSI) | 57.70 | 30.39 |
| Support Level | $6.37 | $2.43 |
| Resistance Level | $7.50 | $3.36 |
| Average True Range (ATR) | 0.23 | 0.21 |
| MACD | 0.05 | -0.01 |
| Stochastic Oscillator | 67.48 | 4.11 |
Materialise NV is a provider of 3D-printed medical devices and software and a pioneer in additive manufacturing software and services. The company operates through three principal segments: Materialise Software, Materialise Medical, and Materialise Manufacturing, with the Materialise Medical segment generating maximum revenue. The Materialise Medical segment develops and delivers medical software solutions, medical devices, and related products and services; the Materialise Software segment develops and delivers additive manufacturing software solutions and related services; and the Materialise Manufacturing segment delivers 3D-printed products and related services. The company generates maximum revenue from the United States of America.
AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.